Cite
Chen CT, Chen YC, Du Y, et al. A tumor vessel-targeting fusion protein elicits a chemotherapeutic bystander effect in pancreatic ductal adenocarcinoma. Am J Cancer Res. 2017;7(3):657-672
Chen, C. T., Chen, Y. C., Du, Y., Han, Z., Ying, H., Bouchard, R. R., Hsu, J. L., Hsu, J. M., Mitcham, T. M., Chen, M. K., Sun, H. L., Chang, S. S., Li, D., Chang, P., DePinho, R. A., & Hung, M. C. (2017). A tumor vessel-targeting fusion protein elicits a chemotherapeutic bystander effect in pancreatic ductal adenocarcinoma. American journal of cancer research, 7(3), 657-672.
Chen, Chun-Te, et al. "A tumor vessel-targeting fusion protein elicits a chemotherapeutic bystander effect in pancreatic ductal adenocarcinoma." American journal of cancer research vol. 7,3 (2017): 657-672.
Chen CT, Chen YC, Du Y, Han Z, Ying H, Bouchard RR, Hsu JL, Hsu JM, Mitcham TM, Chen MK, Sun HL, Chang SS, Li D, Chang P, DePinho RA, Hung MC. A tumor vessel-targeting fusion protein elicits a chemotherapeutic bystander effect in pancreatic ductal adenocarcinoma. Am J Cancer Res. 2017 Mar 01;7(3):657-672. eCollection 2017. PMID: 28401019; PMCID: PMC5385650.
Copy
Download .nbib